Read the list... 14 Low Cost Implant Companies
SMITH & NEPHEW GOES REP-LESS WITH SOME HIPS AND KNEES (Orthopedics This Week)
Smith & Nephew, plc (SNN) expects to cut some orthopedic implant prices in half with a “no-frills” option called Syncera that excludes logistical support or an onsite technician and replaces them with an iPad app.
The program was announced by company CEO Olivier Bohoun at the end of July. Bohoun said the Syncera program could reduce hip and knee device prices by 40% to 50% for the target market of 5% to 10% of U.S. hospitals.
When Wright Medical Group, Inc. offered a similar program in 2013, Bank of America analyst Bob Hopkins called it the “Death of the Device Salesman.” But Wright had less than 5% of the hip and knee market and subsequently sold its ortho business to MicroPort Orthopedics.
Institutional Drivers
Leaders at Wright had hired Baine & Company to figure out how to segment the 6,000 hospital market in the U.S. The Bain report concluded that about 10% of the U.S. hip and knee procedure market is institutionally driven. That was up from about 5% only two or three years ago. The report further concluded that the institutional numbers wer...
